Behrman Capital

Behrman Capital recently executed two transactions, a dividend recapitalisation and spin-off, linked to its $303m acquisition of defense contractor ILC Industries in 2003.

Protective casing manufacturer Pelican Products has acquired Hardigg Industries using 3.5x leverage and $125m in mezzanine financing as Behrman deploys the last of its capital from the firm’s $1.2bn third fund.

The US mid-market firm has purchased an Illinois Tool Works subsidiary as it deploys remaining ‘reserve capital’ for add-ons from its $1.2bn Fund III.

Peter Pace, formerly the US' highest-ranking military official, has joined the New York- and San Francisco-based private equity firm as an operating partner.

New York- and San Francisco-based Behrman Capital has sold WIL Research Laboratories for $500 million, earning a 3.6x return.

Seeking to replicate the success of its investment in post-acute care provider Tandem Health Care, which it exited last year, Behrman Capital has acquired 35 post-acute care facilities for $250 million.

Seeking to replicate the success of its investment in post-acute care provider Tandem Health Care, which it exited last year, Behrman Capital has acquired 35 post-acute care facilities for $250 million.

New York- and San Francisco-based Behrman Capital has sold WIL Research Laboratories for $500 million, earning a 3.6x return.

Konnin Tam, Steve Lessar and Veena Isaac were fired by BlackRock Monday morning to pre-empt their departure, just as the firm returned to market with a new secondaries fund.

LPs can find the options are limited when a fund manager restructures the leftover assets in a fund nearing the end of its life.

Andrew Caspersen will focus on the growing need of GPs to restructure aging funds that are approaching the end of their lives.

Andrew Caspersen will focus on the growing need of GPs to restructure aging funds that are approaching the end of their lives.

The firm has hired 20-year healthcare veteran Mark Visser as managing director and leader of healthcare activities, a newly created position.

The mid-market private equity firm held a final close on its $500m target for Fund II, and promoted a number of staff to senior positions.

While stressing it continues to honour capital calls, CalPERS has said it is not atypical for it to ask GPs to delay requests for funds. The pension has confirmed it sold more than $2bn in private equity holdings on the secondary market last year, including interests in Carlyle and Landmark funds.

The London-listed affiliate of American Capital has made its final exit from supplier of industrial weighing machines Avery Weigh-Tronix in a deal worth around €100m, having already disposed of the business’ retail arm last September.